1. Home
  2. TNC vs ANAB Comparison

TNC vs ANAB Comparison

Compare TNC & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$86.70

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$52.91

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNC
ANAB
Founded
1870
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
TNC
ANAB
Price
$86.70
$52.91
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$79.00
$71.67
AVG Volume (30 Days)
154.0K
640.4K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
91.02
EPS
0.01
N/A
Revenue
$1,137,600,000.00
$234,603,000.00
Revenue This Year
$5.77
N/A
Revenue Next Year
$4.95
$52.14
P/E Ratio
$8,579.00
N/A
Revenue Growth
N/A
157.01
52 Week Low
$60.18
$17.11
52 Week High
$91.93
$73.30

Technical Indicators

Market Signals
Indicator
TNC
ANAB
Relative Strength Index (RSI) 50.15 41.08
Support Level $83.41 $52.32
Resistance Level $87.65 $57.70
Average True Range (ATR) 2.47 4.98
MACD -0.19 -1.66
Stochastic Oscillator 52.99 15.21

Price Performance

Historical Comparison
TNC
ANAB

About TNC Tennant Company

Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: